Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance.
- Published Article
- Publication Date
Oct 01, 1984
Circulating myeloblasts were obtained from patients with acute myelogenous leukemias varying widely in anthracycline responsiveness. Studies were carried out in vitro to assess the capacity of such cells for daunorubicin accumulation. There was no correlation between drug responsiveness patterns in vivo vs. drug transport phenomena measured in vitro. A mode of enhanced anthracycline exodus demonstrable in certain drug-resistant murine leukemia cell lines could not be detected in the drug-resistant human myeloblasts.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/01/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/6594191